Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

366 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The role of MDR-1 in refractory lymphoma.
Sandor V, Wilson W, Fojo T, Bates SE. Sandor V, et al. Among authors: bates se. Leuk Lymphoma. 1997 Dec;28(1-2):23-31. doi: 10.3109/10428199709058327. Leuk Lymphoma. 1997. PMID: 9498700 Review.
New strategies in peripheral T-cell lymphoma: understanding tumor biology and developing novel therapies.
Dunleavy K, Piekarz RL, Zain J, Janik JE, Wilson WH, O'Connor OA, Bates SE. Dunleavy K, et al. Among authors: bates se. Clin Cancer Res. 2010 Dec 1;16(23):5608-17. doi: 10.1158/1078-0432.CCR-09-1995. Clin Cancer Res. 2010. PMID: 21138864 Free PMC article. Review.
A phase I study of the P-glycoprotein antagonist tariquidar in combination with vinorelbine.
Abraham J, Edgerly M, Wilson R, Chen C, Rutt A, Bakke S, Robey R, Dwyer A, Goldspiel B, Balis F, Van Tellingen O, Bates SE, Fojo T. Abraham J, et al. Among authors: bates se. Clin Cancer Res. 2009 May 15;15(10):3574-82. doi: 10.1158/1078-0432.CCR-08-0938. Epub 2009 May 5. Clin Cancer Res. 2009. PMID: 19417029 Free PMC article. Clinical Trial.
Population pharmacokinetics of romidepsin in patients with cutaneous T-cell lymphoma and relapsed peripheral T-cell lymphoma.
Woo S, Gardner ER, Chen X, Ockers SB, Baum CE, Sissung TM, Price DK, Frye R, Piekarz RL, Bates SE, Figg WD. Woo S, et al. Among authors: bates se. Clin Cancer Res. 2009 Feb 15;15(4):1496-503. doi: 10.1158/1078-0432.CCR-08-1215. Clin Cancer Res. 2009. PMID: 19228751 Free PMC article. Clinical Trial.
Cardiac studies in patients treated with depsipeptide, FK228, in a phase II trial for T-cell lymphoma.
Piekarz RL, Frye AR, Wright JJ, Steinberg SM, Liewehr DJ, Rosing DR, Sachdev V, Fojo T, Bates SE. Piekarz RL, et al. Among authors: bates se. Clin Cancer Res. 2006 Jun 15;12(12):3762-73. doi: 10.1158/1078-0432.CCR-05-2095. Clin Cancer Res. 2006. PMID: 16778104 Clinical Trial.
Changing the paradigms of treatment in peripheral T-cell lymphoma: from biology to clinical practice.
O'Connor OA, Bhagat G, Ganapathi K, Pedersen MB, D'Amore F, Radeski D, Bates SE. O'Connor OA, et al. Among authors: bates se. Clin Cancer Res. 2014 Oct 15;20(20):5240-54. doi: 10.1158/1078-0432.CCR-14-2020. Clin Cancer Res. 2014. PMID: 25320373 Review.
Strategies for reversing drug resistance.
Fojo T, Bates S. Fojo T, et al. Among authors: bates s. Oncogene. 2003 Oct 20;22(47):7512-23. doi: 10.1038/sj.onc.1206951. Oncogene. 2003. PMID: 14576855 Review.
Increased 99mTc-sestamibi accumulation in normal liver and drug-resistant tumors after the administration of the glycoprotein inhibitor, XR9576.
Agrawal M, Abraham J, Balis FM, Edgerly M, Stein WD, Bates S, Fojo T, Chen CC. Agrawal M, et al. Among authors: bates s. Clin Cancer Res. 2003 Feb;9(2):650-6. Clin Cancer Res. 2003. PMID: 12576431 Clinical Trial.
A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonist.
Abraham J, Bakke S, Rutt A, Meadows B, Merino M, Alexander R, Schrump D, Bartlett D, Choyke P, Robey R, Hung E, Steinberg SM, Bates S, Fojo T. Abraham J, et al. Among authors: bates s. Cancer. 2002 May 1;94(9):2333-43. doi: 10.1002/cncr.10487. Cancer. 2002. PMID: 12015757
366 results
Jump to page
Feedback